Patent containing claim to single medicinal ingredient not eligible to be listed against combination product
On April 3, 2014, Prothonotary Milczynski granted Teva’s 6(5)(a) motion finding that Canadian Patent No. 2,289,753 is not eligible to be listed...Read More
US Supreme Court Clarifies Law of Ambiguity
The US Supreme Court has restated the test for determining whether a patent claim is indefinite (or ambiguous) in its recent decision...Read More